Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein

Digestion

Volumn 58, Issue 2, 1997, Pages 176-180

  Røseth, Arne G ^a   Aadland, Erling ^a   Jahnsen, Jørgen ^a   Raknerud, Nils ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Assessment; Colonoscopy; Faecal calprotectin; Ulcerative colitis; Ulcerative colitis activity

Indexed keywords

CALPROTECTIN; MARKER; PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; GRANULOCYTE; HISTOLOGY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOOD PROTEINS; BLOOD SEDIMENTATION; COLITIS, ULCERATIVE; COLONIC DISEASES; ENDOSCOPY; FECES; FEMALE; GRANULOCYTES; HEMOGLOBINS; HISTOCYTOCHEMISTRY; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; SERUM ALBUMIN;

EID: 0030897788     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201441     Document Type: Article

References (17)

1. Gomes P, Du Bolay C, Smith CL, Holdstock G: Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986: 27:92-95.
2. Baron JH, Conell AM, Lennard-Jones JE: Variation between observers in describing mucosal appearances in proctocolitis. BrMed J 1964;iv: 89-92.
3. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS: Indiurn-111-granulocyte scanning in the assessment of disease activity in inflammatory bowel disease. Gastroenterology 1986:90:1121-1228.
4. Moran A, Jones A, Asquith P: Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn's colitis. Scand J Gastroenterol 1995:30:356-360.
5. Fagerhol MK, Andersson KB, Naess-Andersen CF, Brandtzaeg P, Dale I: Calprotectin (the LI leukocyte protein); in Smith VL. Dedman JR (eds): Stimulus Response Coupling: The Role of Intracellular Calcium-Binding Proteins. Boca Raton. CRC Press. 1990, pp 187-210.
6. Bjerke K, Halstcnsen IS, Jahnsen F, Pulford K, Brandtzaeg P: Distribution of macrophages and granulocytes expressing LI protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 1993:34:1357-1363.
7. Brandtzaeg P, Dale I, Gabrielscn T-0 The leucocyte protein LI (calprotectin): Usefulness as an immunohistoehemical marker and putative biological function. Histopathology 1992:21: 191-196.
8. Brun GJ, Jonsson R, Haga H-J: Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic disease. J Rheumatol 1994: 21:733-738.
9. Bemtzen HB, Munthe E, Fagerhol MK: A longitudinal study of the leucocyte protein LI as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989:16: 1416-1420.
10. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H: Assessment of the neutrophil dominating protein calprotectin in feces: A methodological study. Scand J Gastroenterol I992;27:793-798.
11. Sandbome WJ, Tremaine WJ, Schroeder KW, Batts KO, Lawson GM, Steiner BL, Harrison JM, Zinsmeister AR: A placebo-controlled trial of cyclosporin enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology 1994;106:1429-1435.
12. Farup PG, Hovde O, Halvorsen FA, Raknerud N, Brodin U: Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. Stand J Gastroenterol 1995:30: 164-170.
13. Binder V: A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol 1970:5:627-632.
14. Uchida K, Matsuse R, Tornita S, Sugi K, Saitoh O. Ohshiba S: Immunochemical detection of human lactoferrin in feces as a new marker of inflammatory gastrointestinal disorders and colon cancer. Clin Biochem 1994;27:259-264.
15. Roseth AG, Schmidt PN, Fagerhol MK: Fecal calprotectin correlates with excretion of "'ln-labellcd granulocytes in inflammatory bowel disease. 10th World Congress of Gastroenterology, 1994, p 561.
16. Kjcldscn J, Schaffaiitzky De Muckadell OB: Assessment of disease severity and activity in inflammatory bowel disease. Scand J Gastroenterol 1993:28:1-9.
17. Adcyemi EO, Hodgson HJF: Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 1992:27:139-142.